The research of J. Taylor Hays, M.D., focuses on tobacco dependence and its treatment, including pharmacological and behavioral therapies. His research includes clinical trials of novel pharmacologic treatments for tobacco dependence as well as the study of tobacco dependence treatment in people with a current or past history of other substance abuse problems, such as alcohol dependence.
- Study of the nicotine receptor partial agonist varenicline for tobacco dependence treatment
- Study of the treatment of tobacco dependence among smokers with current or past alcohol abuse or dependence
- Dissemination of evidence-based tobacco dependence treatment to health care providers within and outside the U.S.
Significance to patient care
Tobacco use and dependence remains the number one cause of preventable and premature death in the U.S. Effective treatment will help people who are tobacco dependent become smoke-free and reduce their risk of premature death and disease.
- Associate Director, Nicotine Dependence Center, Mayo Clinic
- Chair, Personnel Committee, Mayo Clinic in Rochester, Minn.
- Distinguished Clinician Award, Mayo Clinic, 2011
- Diplomate, American Board of Addiction Medicine, 2010
- Fellow, American College of Physicians, 2008